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Background: Fructose administration rapidly induces oxidative stress that triggers compensatory hepatic meta-
bolic changes. We evaluated the effect of an antioxidant, R/S-α-lipoic acid on fructose-induced oxidative stress
and carbohydrate metabolism changes.
Methods:Wistar rats were fed a standard commercial diet, the same diet plus 10% fructose in drinking water, or
injected with R/S-α-lipoic acid (35 mg/kg, i.p.) (control + L and fructose + L). Three weeks thereafter, blood
samples were drawn to measure glucose, triglycerides, insulin, and the homeostasis model assessment-insulin
resistance (HOMA-IR) and Matsuda indices. In the liver, we measured gene expression, protein content and ac-
tivity of several enzymes, and metabolite concentration.
Results: Comparable body weight changes and calorie intake were recorded in all groups after the treatments.
Fructose fed rats had hyperinsulinemia, hypertriglyceridemia, higher HOMA-IR and lowerMatsuda indices com-
pared to control animals. Fructose fed rats showed increased fructokinase gene expression, protein content and
activity, glucokinase and glucose-6-phosphatase gene expression and activity, glycogen storage, glucose-6-
phosphate dehydrogenase mRNA and enzyme activity, NAD(P)H oxidase subunits (gp91phox and p22phox) gene
expression and protein concentration and phosphofructokinase-2 protein content than control rats. All these
changes were prevented by R/S-α-lipoic acid co-administration.
Conclusions: Fructose induces hepatic metabolic changes that presumably begin with increased fructose
phosphorylation by fructokinase, followed by adaptive changes that attempt to switch the substrate ﬂow from
mitochondrial metabolism to energy storage. These changes can be effectively prevented by R/S-α-lipoic acid
co-administration.
General signiﬁcance: Control of oxidative stress could be a useful strategy to prevent the transition from impaired
glucose tolerance to type 2 diabetes.© 2014 Elsevier B.V. All rights reserved.1. Introduction
Several authors have suggested that the increased use of reﬁned car-
bohydrates such as fructose-rich syrups has greatly contributed to the
epidemics of obesity and type 2 diabetes [1,2]. Additionally,many inves-
tigators have demonstrated that administration of fructose-rich diets to
normal rats induces several metabolic and endocrine dysfunctions, af-
fecting many tissues and organs [3–6]. Since the liver is primarily re-
sponsible for fructose uptake and metabolism, a number of studies
have dealt with its effect on hepatic glucosemetabolism [7,8]. Although
the underlying mechanism of fructose-induced detrimental effects is
not fully understood, experimental evidence suggests that oxidative
stress could play a key role [9–12]. In this regard, we have previouslysment-insulin resistance; FPI,
FK-2, phosphofructokinase 2;
A PLATA), Facultad de Ciencias
a).
t of this work.
ights reserved.demonstrated that short-term fructose administration to normal rats
induces a signiﬁcant enhancement of oxidative stressmarkers in several
organs including the liver [3,4], associated insulin resistance, a switch of
hepatic carbohydrate and lipid metabolism towards its anabolic path-
way and impaired glucose tolerance [5,6,13,14].
If the above-mentioned changes were speciﬁcally linked to fructose-
induced oxidative stress, then the administration of an antioxidant
agent should prevent/alleviate the development of oxidative stress.
Supporting this assumption, we have previously shown that co-
administration of an antioxidant, R/S-α-lipoic acid to fructose-fed rats
prevents both oxidative stress and most of the endocrine-metabolic
dysfunctions triggered by fructose [15]. We do not know, however,
the potential molecular link between fructose-induced oxidative stress
and the resultant impaired carbohydrate metabolism. In the series of
experiments herein described we examined the effect of R/S-α-lipoic
acid co-administration on carbohydrate metabolism in fructose-fed
rats in order to clarify the adaptive mechanisms involved in fructose-
induced oxidative stress that may be the basis for strategies for our
understanding of obesity and type 2 diabetesmellitus frequently associ-
ated with high fructose consumption.
Table 1
Primer sequences.
Gene GenBank® Sequences
Fructokinase NM_031855.3 FW 5′-ACGGATCGCAGGTGCCTAT-3′
RV 5′-AGCACAGTGCAGGAGTTGGA-3′
Glucose-6-phosphatase NM_013098.2 FW 5′-GATCGCTGACCTCAGGAACGC-3′
RV 5′-AGAGGCACGGAGCTGTTGCTG-3′
Glucose-6-phosphate
dehydrogenase
NM_017006.2 FW 5′-TTCCGGGATGGCCTTCTAC-3′
RV 5′-TTTGCGGATGTCATCCACTGT-3′
Glucokinase NM_012565.1 FW 5′-GTGTACAAGCTGCACCCGA-3′
RV 5′-CAGCATGCAAGCCTTCTTG-3′
PFK-2 NM_012621.4 FW 5′-CGATCTATCTACCTATGCCGCCAT-3′
RV 5′-ACACCCGCATCAATCTCATTCA-3′
gp91phox NM_023965.1 FW 5′-CCAGTGTGTCGGAATCTCCT-3′
RV 5′-ACACCACTCCACGTTGAACA-3′
p22phox NM_024160.1 FW 5′-CACGCAGTGGTACTTTGGTG-3′
RV 5′-CACGGACAGCAGTAAGTGGA-3′
β-Actin NM_031144.2 FW 5′-AGAGGGAAATCGTGCGTGAC-3′
RV 5′-CGATAGTGATGACCTGACCGT-3′
FW, forward primer. RV, reverse primer.
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2.1. Chemicals and drugs
Reagents of the purest available grade were obtained from Sigma
Chemical Co. (St. Louis, MO, USA). An injectable solution (Megatioc®)
of R/S-α-lipoic acid was purchased from John Martin S.R.L (Buenos
Aires-Argentina).
2.2. Animals
Normal male Wistar rats (150–180 g) were maintained at 23 °C
with a ﬁxed 12-h light–dark cycle (06:00–18:00 h) and divided in 4
groups: standard commercial diet ad libitum and tap water (control),
the same diet plus 10% fructose in the drinking water (fructose), and
two additional groups that were injected with R/S-α-lipoic acid
(35 mg/kg, i.p) (control + L and fructose + L) during the last ﬁve
days of treatment. Control and fructose animals were injected with
the same volume of saline buffer. Water intake was measured daily,
and individual body weight was recorded weekly. This procedure was
replicated 5 times (total, 20 animals per group). Twenty-one days
after this treatment, blood samples from 4-h fasted animals were
drawn from the retroorbital plexus under light halothane anesthesia
and collected into heparinized tubes to measure blood glucose, serum
triglyceride and immunoreactive insulin levels. Afterwards, the animals
were killed by decapitation and a portion of themedian lobe of the liver
was removed to perform all the assays. When the assays were not per-
formed immediately, the lobe was quickly immersed in liquid nitrogen
and thereafter stored in a deep freezer at−80 °C; all enzyme activities
were measured within a week. Animal experiments and handling were
performed according to the “Ethical principles and guidelines for exper-
imental animals” (3rd Edition 2005) of the Swiss Academy of Medical
Sciences.
2.3. Serum measurements
Glucose was measured with the glucose-oxidase GOD-PAP meth-
od (Roche Diagnostics, Mannheim, Germany), triglyceride levels
were determined with a commercial kit (TG color GPO/PAP AA,
Wiener lab, Argentina) and immunoreactive insulin levels were de-
termined by radioimmunoassay (Linco Research Inc., IN, USA).
Serum insulin and fasting glycemia values were used to estimate
the homeostasis model assessment-insulin resistance (HOMA-IR)
(serum insulin (μU/ml) × fasting blood glucose (mM)) / 22.5 [16].
The Matsuda index (hepatic insulin sensitivity) was calculated
with the formula k / fasting plasma insulin (FPI) × fasting plasma
glucose (FPG), where k: 22.5 × 18 [17].
2.4. Isolation of total RNA
Total liver RNAwas isolated using TRIzol® Reagent (Gibco) [18]. Re-
verse transcription-PCR (RT-PCR) was performed using the SuperScript
III (Invitrogen, USA) and total RNA from the rat livers as a template.
2.5. Gene expression by real-time PCR (qPCR) (quantitative PCR)
qPCR was performed with a Mini Opticon Real-Time PCR Detector
Separate MJR (Bio-Rad Laboratories), using SYBR Green I as a ﬂuores-
cent dye. Then 10 ng of cDNAwas ampliﬁed in 25 μl of the reactionmix-
ture containing 0.6 μMof each primer, 3 mMMgCl2, 0.2 mMdNTPs and
0.15 μl of platinum Taq DNA polymerase (6 units/μl; Invitrogen, USA).
Samples were ﬁrst denatured at 95 °C for 3 min followed by 40 PCR cy-
cles (a melting step at 95 °C for 30 s, an annealing step at 62 °C for 45 s
and an extension step at 72 °C for 30 s), followed by a ﬁnal extension at
72 °C for 10 min. The oligonucleotide primers (forward and reverse)
(Invitrogen) used are listed in Table 1. All amplicons were designed ina size range of 90–288 bp. The speciﬁcity of the primers was double
checked: a) performing an endpoint PCR and determining a single
amplicon at the predicted size and b) measuring the melting curves in
the qPCR system and controlling the existence of a single pick. The efﬁ-
ciency of the primers employedwas calculated after performing calibra-
tion curves using different quantities of cDNA. Results are expressed as
relative gene expression after normalization to the β-actin housekeep-
ing gene using the Qgene96 and LineRegPCR software [19].
2.6. Western blot analysis
Immunodetection of glucokinase, phosphofructokinase 2 (PFK-2),
fructokinase, p22phox and β-actin was done in liver homogenates. Pro-
tein concentration was quantiﬁed by the Bio-Rad protein assay [20].
Thereafter, dithiothreitol and bromophenol blue were added to a ﬁnal
concentration of 100 mM and 0.1%, respectively. Nonspeciﬁc binding
sites of the membranes were blocked by previous overnight incubation
with non-fat dry milk at 4 °C. Enzyme identiﬁcation and quantiﬁcation
were performed using speciﬁc primary antibodies (Table 2). Diamino-
benzidine (Sigma Co.) or enhanced chemiluminescence (GEHealthcare,
UK) was used for color development. Finally, the bands were quantiﬁed
by densitometry using the Gel-Pro Analyser software. β-Actin density
was used to normalize the protein content: the target protein relative
content was divided by the relative β-actin protein level in each group.
2.7. Liver glycogen content
Pieces of fresh liver (400 mg) were placed in 1 ml of 33% KOH and
incubated for 20 min at 100 °C. Then, 1.25 ml of ethanol was added to
each tube and the mixture was incubated for 48 h at 4 °C and ﬁnally
centrifuged at 700 ×g for 20 min. The pellets obtainedwere resuspend-
ed in 1 ml of distilled water plus 3 ml of Antrone solution (0.1% in 84%
H2SO4) and incubated for 20 min at 100 ° C. The absorbance was mea-
sured photometrically at 620 nm and the results expressed as μmol of
glycogen/mg of tissue [21].
2.8. Liver fructokinase activity
Pieces of liver were homogenized in buffer containing 25 mMHEPES
(pH 7.1), 100 mM KCl, 1 mM DTT, and 0.1 mM EDTA; they were then
spun at 10,000 ×g at 4 °C for 20 min and aliquots of the supernatant
were frozen for further activity assay. To measure FK activity we used a
coupled enzymatic assay based on existing methods [22]. Brieﬂy,
10–20 μl of the samplewere added to 200 μl of the reactionmixture con-
taining of 25 mM HEPES (pH 7.1), 6 mM MgCl2, 25 mM KCl, 10 mM
NaF, 5 mM D-fructose, 0.2 mM NADH, 1 mM phosphoenolpyruvate,
Table 2
Western blot protocol.
Protein
(MW)
Whole protein (μg) SDS-PAGE
%
Primary antibody dilution T (h) Secondary antibody dilution T (m) D
Fructokinase (33) 100 12.5 Anti-fructokinase 1:1000 16 Peroxidase-conjugated anti-goat IgG 1:10,000 90 ECL
Glucokinase (60) 20 10 Anti-glucokinase 1:2000 1.5 Anti-sheep IgG 1:2000
Streptavidin–peroxidase conjugate 1:2000
30
30
DAB
PFK-2 (58) 200 10 Anti-PFK-2 1:10,000 2 Peroxidase-conjugated anti-chicken IgG 1:400,000 60 DAB
p22phox (22) 100 12.5 Anti- p22phox 1:200 2.5 Peroxidase-conjugated anti-rabbit IgG 1:10,000 90 DAB
β-actin (42) 20–200 10–12.5 Anti- β-actin 1:10,000 1 Anti-mouse IgG 1:2000
Streptavidin–peroxidase conjugate 1:2000
30
30
DAB
MW: molecular weight; T: time; h: hours; m: minutes; D: method used for developing.
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N-acetyl-D-glucosamine (to inhibit hexokinase but retain fructokinase
activity). The reaction was started by adding 10 μl of ATP (5 mM ﬁnal
concentration) and quantitatively measured accordingly to a decrease
of optical density at 340 nm during 30 min.
2.9. Liver glucokinase activity
Liver pieces removed from the animals were homogenized in ice-
cold PBS containing 0.1 mM PMSF, 0.1 mM benzamidine, 2 mM DTT,
4 μg/ml aprotinin and 0.3 M sucrose, pH 7.5. Aliquots of these homoge-
nates were centrifuged at 600 ×g to separate the nuclear fraction. The
supernatant was centrifuged twice at 8000 and 100,000 ×g at 4 °C,
and the resultant supernatant was collected and identiﬁed as the cyto-
solic fraction (cf), which contains the active functional form of the en-
zyme. Thereafter, the nuclear fraction, containing the inactive form of
glucokinase due to its binding with its regulatory protein, was re-
suspended and incubated for 12 min at 20 °C in a permeabilizingmedi-
um containing 150 mmol/ml KCl, 3 mmol/l Hepes, 2 mmol/l DTT, and
0.04 mg/ml digitonin, pH 7.2. At the end of this incubation, samples
were centrifuged (600 ×g) and the digitonin supernatant was removed
and collected for further determinations (nf). Digitonin treatment al-
lows the release of glucokinase from its regulatory protein, rendering
a soluble and active glucokinase. Glucokinase activity was ﬁnally mea-
sured in aliquots of both liver fractions and the activity ratio for cf/nf
considered as an indirectmeasurement of nucleus/cytosol translocation
[5]. Rates of glucose phosphorylation in both fractionsweremeasured at
37 °C, pH 7.4, by recording the increase in absorbance at 340 nm in a
well-established enzyme-coupled photometric assay [5,23]. Glucoki-
nase activity was obtained by subtracting the activity measured at
1 mM glucose (hexokinase) from that measured at 100 mM glucose.
Enzyme activity is expressed as m-units/mg of protein. One unit of en-
zyme activity was deﬁned as 1 μmol of glucose-6-phosphate formed
from glucose and ATP/min at 37 °C.
2.10. Liver glucose-6-phosphatase activity
Homogenization of liver samples and isolation of microsomes were
carried out as described byNordlie & Arion [24]. Homogenizationmedi-
um was 0.25 M sucrose/5 mM Tris-acetate/0.5 mM EDTA, pH 7.4. Mi-
crosomes were washed once with 0.25 M sucrose/5 mM Tris-acetate,
pH 7.4, and centrifuged at 100,000 ×g. Fully disrupted microsomes
were prepared at 0 °C by adding 0.1 ml of 0.75% Triton X-100 to
0.9 ml of untreated microsomes (approximately 10 mg of protein)
and allowed to stand on ice for 20 min. Then 50 μl of the mixture and
50 μl of glucose-6-phosphate sodium salt (0.8 M)were added and sam-
ples were incubated for 10 min at 30 °C. The reaction was stopped by
adding 250 μl of 10% trichloroacetic acid; then, 2 ml of MoNH4 (diluted
in 1 M H2SO4) plus 320 μl of FeSO4 (diluted in 0.15 M H2SO4) were
added to 200 μl of each sample. The activity of glucose-6-phosphatase
was determined by measuring the release of inorganic phosphate
from glucose-6-phosphate. The absorbance was photometrically read
against a reagent blank at 660 nm and results were expressed as‘latency’, calculated according to the following formula: 100 × (activity
in disrupted microsomes − activity measured in untreated microso-
mes) / activity measured in disrupted microsomes.
2.11. Liver glucose-6-phosphate dehydrogenase activity
Pieces of liver were homogenized in 0.1 M Tris/HCl and 1 mM EDTA,
pH 7.6 (10 ml/g of tissue). The homogenate was centrifuged for 15 min
at 10,000 ×g and enzyme activity was measured in the supernatants by
recording the changes in absorbance at 340 nm in a well-established
enzyme-coupled photometric assay as described by Beutler [25]. Brieﬂy
the sample was added to the buffer assay (Tris–HCl 1 M, EDTA 5 mM,
pH 8, MgCl2 0,1 M and NADP+ 2 mM), and incubated for 10 min at
37 °C. Thereafter, the sample was divided into 4 aliquots (tubes 1 to 4):
tube 1 without sample, tube 2 plus 6 mM G-6-P, tube 3 plus 6 mM 6-
phosphogluconate and tube 4 plus both compounds. The glucose-6-
phosphate dehydrogenase activity was calculated by subtracting the ac-
tivity measured in tube 3 from that of tube 4 [25]. Glucose-6-phosphate
dehydrogenase catalyzes the oxidation of glucose-6-phosphate to 6-
phosphogluconolactone, which quickly and spontaneously hydrolyzes
to 6-phosphogluconate. In the next step, 6-phosphogluconate dehydro-
genase catalyzes the oxidation of 6-phosphogluconate to ribulose-5-
phosphate andCO2. Theseprocedures allow the simultaneous calculation
of glucose-6-phosphate dehydrogenase activity in the standard way as
well as the glucose-6-phosphate dehydrogenase activity as corrected
for 6-phosphogluconate dehydrogenase activity [25].
2.12. Statistical analysis
Results are expressed as means ± SEM for the indicated number of
observations. Statistical analysis was performed using ANOVA followed
by Dunnett's test formultiple comparisons using the Prism analysis pro-
gram (GraphPad). The Bartlett's test was employed to assess variances
homogeneity. Differences were considered signiﬁcant when p b 0.05.
3. Results
3.1. Body weight and water intake
Comparable body weight changes were recorded in all groups over
the 3-week study period (Table 3). Fructose fed and fructose + L ani-
mals drank a larger volume of water than control and control + L
(55 ± 11 and 47 ± 12 vs. 29 ± 2 and 28 ± 2 ml/day, respectively;
p b 0.05). Conversely, control and control + L rats ate signiﬁcantly
more solid food than fructose and fructose + L rats (21 ± 1 and
22 ± 1 vs. 16 ± 1 and 17 ± 1 g/animal/day; p b 0.05). Consequently,
while the daily intake of nutrients (expressed as percentage)was differ-
ent in the experimental groups (carbohydrates/protein/lipids 45:43:12
for control and control + L compared to 59:32:9 and 57:34:9 for fruc-
tose and fructose + L respectively), their calorie intakewas comparable
(control: 58 ± 3; control + L: 65 ± 2; fructose: 66 ± 5; fructose + L:
66 ± 4 kcal/day). The daily calorie intake was calculated based on the
amount of daily intake of nutrients (solid food plus the fructose in the
Fig. 1. Liver fructokinase expression and activity. Liver fructokinase gene expression
(A), protein content (B and D) and activity (E). (B) Representative blots show the
bands corresponding to fructokinase protein or β-actin protein (C) in control,
control-L, fructose and fructose-L (C, CL, F and FL respectively). (D) Band intensities
were measured in control (white bar), control-L (horizontal lines bar), fructose
(black bar) and fructose-L (diagonal lines bar) animals. Results are means ± SEM
of 5 different experiments ran in triplicate. ap b 0.05 vs. C, and bp b 0.05 vs. F animals.
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calories.
3.2. Serum measurements
Fructose-fed rats had higher serum insulin and triglyceride concen-
trations than control rats (Table 3). The highMatsuda index andHOMA-
IR values measured in fructose-fed rats demonstrated the presence of a
decrease in insulin sensitivity both in the liver and in the other periph-
eral tissues as well (Table 3). Co-administration of R/S-α-lipoic acid to
these rats prevented the development of all the metabolic and endo-
crine changes as well as the decreased hepatic and general response
to insulin; consequently, the different parameters tested attained values
comparable to those recorded in control rats; this effectwas even great-
er for triglycerides, in which triglyceride concentrations were lower
than those recorded in control rats (Table 3).
3.3. Liver fructokinase gene expression, protein content and activity
Fructose-fed rats had increased fructokinase gene expression, pro-
tein content and activity, changes that were prevented by R/S-α-lipoic
acid administration (Fig. 1A, B and C, respectively).
3.4. Liver glucokinase gene expression, protein content and activity
Glucokinase gene expressionmeasured in liver homogenates was
higher in fructose-fed compared to control rats, but the difference
was not statistically signiﬁcant (control, 1.36 ± 0.26 vs. fructose,
2.4 ± 0.69, relative gene expression × 1000). Nevertheless, its ex-
pression in fructose + L animals was similar to that seen in control
rats (fructose + L, 1.58 ± 0.47, relative gene expression × 1000).
Glucokinase protein content was comparable in all groups, suggesting
that itwas not signiﬁcantly affected either by fructose or by R/S-α-lipoic
acid co-administration (Fig. 2A).
On the other hand, when enzyme activity was measured indepen-
dently in the cytosol (cf) (active form of the enzyme) and in the nuclear
(nf) (inactive form) fractions of liver homogenates, it was higher in the
nf than in the cf fraction of control, control + L and fructose + L ani-
mals. This was reversed in the fructose-fed animals (Fig. 2B–C). These
results demonstrate a different nucleus/cytosolic translocation rate
among the experimental groups.
3.5. Liver PFK-2 protein content
Fructose-fed animals had a signiﬁcantly higher PFK-2 protein con-
tent than the controls. This increment was prevented by R/S-α-lipoic
acid co-administration (Fig. 2D–E).
3.6. Liver glucose-6-phosphatase gene expression and activity
Rats fed fructose had a higher glucose-6-phosphatase gene expres-
sion and activity. This was prevented by R/S-α-lipoic acid co-
administration (Fig. 3A and B).Table 3
Body weight and serummeasurements.
Parameter C
Body weight change (g) 103 ± 6
Insulin (ng/ml) 0.76 ± 0.03
Glucose (mg/dl) 114 ± 5
Triglyceride (g/l) 0.965 ± 0.052
HOMA-IR 5.1 ± 0.2
Matsuda index (k/FPI × FPG) 3.37 ± 0.2
Values are means ± SEM (n = 20).
⁎ p b 0.05 vs. C.
Δ p b 0.05 vs. F.3.7. Liver glucose-6-phosphatase dehydrogenase gene expression and activity
The amount of glucose-6-phosphatase dehydrogenase mRNA and
the enzyme's activity was signiﬁcantly higher in fructose-fed compared
with control animals. Once again, R/S-α-lipoic acid co-administration
prevented these changes (Fig. 3C and D, respectively).
3.8. Liver glycogen content
Supporting our previous report, fructose induced a signiﬁcant in-
crease in glycogen storage that was prevented by R/S-α-lipoic acid co-
administration (Fig. 4).
3.9. NAD(P)H oxidase subunits gene and protein
Fructose-fed rats had a higher relative gene expression of gp91phox
and p22phox than control animals. Co-administration of R/S-α-lipoic
acid prevented this increase (Fig. 5A and B).
A signiﬁcant increase in p22phox protein concentration was recorded
in fructose-fed animals (a single band in the Western blot of about
22 kDa, compatible with the molecular weight of this enzyme). Once
more, this increase was prevented by R/S-α-lipoic acid treatment
(Fig. 5C).CL F FL
92 ± 8 97 ± 5 94 ± 6
0.6 ± 0.08 1.13 ± 0.05⁎ 0.74 ± 0.08Δ
104 ± 4 110 ± 4 115 ± 3
0.45 ± 0.09⁎ 1.63 ± 0.12⁎ 0.71 ± 0.06Δ
3.9 ± 0.6 8.0 ± 0.1⁎ 5.4 ± 0.8Δ
4.68 ± 0.3⁎ 2.3 ± 0.15⁎ 3.43 ± 0.2Δ
Fig. 2.Glucokinase and PFK-2 in rat livers. Glucokinase activity in the cytosolic (cf) anddig-
itonin permeabilized nuclear fraction (nf) (A), ap b 0.05 vs. C cf, bp b 0.05 vs. F cf, cp b 0.05
nf vs. cf, and dp b 0.05 vs. F nf; glucokinase (B and D) and PFK-2 (E and G) protein content
in control, control-L, fructose and fructose-L animals (C, CL, F andFL respectively). (B and E)
Representative blots show the bands corresponding to glucokinase and PFK-2 protein in
control, control-L, fructose and fructose-L animals (C, CL, F and FL respectively). (C and F)
Representative blots show the bands corresponding to β-actin. (D and G) Band intensities
weremeasured in control (white bar), control-L (horizontal lines bar), fructose (black bar)
and fructose-L (diagonal lines bar) animals. Results aremeans ± SEMof 5 different exper-
iments ran in triplicate. ap b 0.05 vs. C, and bp b 0.05 vs. F animals.
1149M.C. Castro et al. / Biochimica et Biophysica Acta 1840 (2014) 1145–11514. Discussion
We have previously shown that normal Wistar rats fed fructose for
21 days developed several generalized metabolic and endocrine disor-
ders [6]. These changeswere accompanied by increasedhepatic concen-
tration of oxidative stress markers and signiﬁcant changes inFig. 3. Liver glucose-6-phosphatase and glucose-6-phosphate dehydrogenase expression
and activity. Liver glucose-6-fosfatase and glucose-6-phosphate dehydrogenase gene
expression (A and C) and activity (B and D) measured in control (white bar), control-L
(horizontal lines bar), fructose (black bar) and fructose-L (diagonal lines bar) animals. Re-
sults are means ± SEM of 5 different experiments ran in triplicate. ap b 0.05 vs. C, and
bp b 0.05 vs. F animals.carbohydrate and lipid metabolism that would channel liver metabo-
lites preferentially to energy storage rather than to mitochondrial
oxidation [5,6,14]. Additionally, using the same animal model, we
recently demonstrated that R/S-α-lipoic acid co-administration
prevented the development of high triglyceride serum concentrations
and hepatic content, probably by decreasing PPARδ and its target
lipogenic gene expression [15]. Thus, these changes would be part of
the mechanisms by which liver compensates the overload of lipid sub-
strates [26], such as it occurs in the fructose-rich model.
As we have earlier reported [5], fructose also induces an increase in
hepatic glucokinase activity. Since the enhanced activity was not
accompanied by signiﬁcant changes in glucokinase gene expression/
protein concentration, the effect primarily resulted from a signiﬁcant
increase in the glucokinase nucleus/cytosol translocation as well as an
increase in PFK2 concentration, a cytosolic glucokinase activator [5].
The current data support those results and demonstrated that co-
administration of R/S-α-lipoic acid to fructose-fed rats drove the values
of nuclear–cytosol ratio and PFK2 content to those recorded in control
animals. We speculate that the fructose-induced increased production
of reactive oxygen species plays an active modulatory role on liver glu-
cokinase activity. Since insulin stimulates glucokinase gene expression
via PI3K [27–29] and fructose-fed rats have hyperinsulinemia, it could
be argued that hyperinsulinemia also contributes to increased glucoki-
nase activity. However, since these rats demonstrated decreased insulin
sensitivity (higher HOMA-IR and lower Matsuda indices in fructose-fed
as compared to control rats), this possibility seems less likely.While the
normal range of those indices is unclear in rodents, the signiﬁcant differ-
ence between the two groups strongly suggests that the fructose-
treated animals have a decreased insulin responsiveness as compared
to control rats not only at the liver (Matsuda index) but also overall
(HOMA-IR).
It has been claimed that timely and rapid metabolic adaptation to
changes in carbohydrate supply is critical tomaintain energy homeosta-
sis and that liver glucose futile cycling plays an important role in such
process [30]. It has also been shown that in mice, hepatic glucose/
glucose-6-phosphate recycling compensates for peripheral glucose
disposal, in order to preserve glucose homeostasis [31]. A comparable
increase in glucokinase and glucose-6-phosphatase activity was mea-
sured in our fructose-fed rats (107 and 141% over the control values, re-
spectively), thus suggesting that this futile cycle could be actively
operating in our model, decreasing the glucose metabolism and the
liver substrates ﬂow to the mitochondria for reactive oxygen species
production. Similarly, the increased activity of glucose-6-phosphate de-
hydrogenase activity (limiting enzyme of the pentose phosphate shut-
tle) and of glycogen and fat deposit in the liver would be part of the
adaptive process because it simultaneously diminishes the overload of
substrates to the mitochondria and enhances the redox power byFig. 4. Liver glycogen content. Glycogen containmeasured in control (white bar), control-L
(horizontal lines bar), fructose (black bar) and fructose-L (diagonal lines bar) animals. Re-
sults are means ± SEM of 5 different experiments ran in triplicate. ap b 0.05 vs. C, and
bp b 0.05 vs. F animals.
Fig. 5.NAD(P)Hoxidase subunit expression. gp91phox andp22phox gene expression (AandB)
and p22phox protein expression. (C and E). (C and D) Representative blots show the bands
corresponding to p22phox and β-actin proteins in control, control-L, fructose and fructose-L
animals (C, CL, F and FL respectively). (E) Band intensities were measured in control
(white bar), control-L (horizontal lines bar), fructose (black bar) and fructose-L (diagonal
lines bar) animals. Results are means ± SEM of 5 different experiments ran in triplicate.
ap b 0.05 vs. C, and bp b 0.05 vs. F animals.
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oxidant role by a complexmechanism that includes the reduction of ox-
idized glutathione to reduced glutathione through the enzyme
glutathione-reductase, acting as coenzyme for peroxidases (via glutathi-
one) and been required for catalase stabilization [32–34]. The fact that
R/S-α-lipoic acid co-administration prevented all these changes rein-
forces our original interpretation.
The fact that R/S-α-lipoic acid co-administration blunted the
fructose-induced increased gene expression and protein level of
NAD(P)H oxidase subunit p22phox (there was a simultaneous non-
signiﬁcant reduction in gp91phox) also suggests the existence of a link
between mitochondrial and cytosolic reactive oxygen species produc-
tion. This possibility merits further research.
Our fructose-fed rats had a signiﬁcant increase of fructokinase
mRNA, protein level and activity supporting the ﬁndings of others
using either fructose- or sucrose-rich diets [35–37]. On the other
hand, fructose induced increases in fructokinase gene expression, pro-
tein level and activity in cultured hepatocytes [22]. Additionally, it has
been demonstrated that fructose stimulates its own metabolism by in-
ducing liver fructokinase expression [38,39] and establishing a vicious
cycle, i.e., increased phosphorylation and increased metabolism, thus
potentiating the deleterious effect of fructose upon hepatic metabolism
[40]. Consistent with these data, patients with non-alcoholic fatty liver
disease (NAFLD) portray twice as high fructokinase activity than the
general population associated with a signiﬁcantly higher consumption
of sweetened beverages (rich in fructose) [22]. The fact that R/S-α-
lipoic acid co-administration to our fructose-fed rats prevented the
fructokinase changes strongly suggests that the enzyme activity not
only depends on fructose overload but additionally on the positive feed-
back effect of some down-stream metabolite or signal. In this regard,
the redox state of the hepatocyte could be a potential candidate:
compelling evidence indicates that enhanced levels of radical oxygen
species can modify protein activity or even alter its conformation
[41]. However, an oxidative stress-mediated speciﬁc alteration in
fructokinase structure is only hypothetical and needs further exper-
imental support.5. Conclusion
In brief, our results show that fructose inducesmanymetabolic chang-
es in the liver that likely begin with an increase in fructose phosphoryla-
tion by fructokinase followed by adaptive changes that attempt to switch
the substrate ﬂow frommitochondrial metabolism to energy storage. All
these changes are essentially prevented by co-administration of R/S-α-
lipoic acid. Therefore, oxidative stress together with fructokinase appear
to be keymediators of themetabolic changes induced by fructose. The re-
duction of fructokinase activity by R/S-α-lipoic acid suggests that some
oxidative stress compound or a metabolite produced subsequently acts
as a positive feedback tomaintain its high levels in fructose-fed rats. Iden-
tiﬁcation of such an active link, and of the effect of antioxidants in the pre-
vention of the transition from impaired glucose tolerance to diabetes
merits further studies.
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